We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+3.52%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$106M
AUM Growth
-$9.79M
Cap. Flow
-$11.7M
Cap. Flow %
-11.08%
Top 10 Hldgs %
41.69%
Holding
64
New
5
Increased
8
Reduced
30
Closed
14

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$4.03M
2
VIPS icon
Vipshop
VIPS
+$2.9M
3
AMP icon
Ameriprise Financial
AMP
+$2.62M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.49M
5
AMAT icon
Applied Materials
AMAT
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 21.23%
2 Technology 19.13%
3 Consumer Discretionary 17.87%
4 Financials 17.27%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JD icon
1
JD.com
JD
$43.5B
$8.3M 7.86%
243,500
+92,500
+61% +$3.15M
AAPL icon
2
Apple
AAPL
$4.97T
$6.73M 6.37%
214,740
-1,200
-0.6% -$38.4K
BX icon
3
Blackstone
BX
$104B
$4.84M 4.58%
120,701
-611
-0.5% -$25.1K
GS icon
4
Goldman Sachs
GS
$289B
$4.09M 3.87%
19,600
+4,150
+27% +$846K
META icon
5
Meta Platforms (Facebook)
META
$1.49T
$4.04M 3.82%
47,050
+8,300
+21% +$678K
MS icon
6
Morgan Stanley
MS
$319B
$3.96M 3.75%
102,100
+20,600
+25% +$784K
GILD icon
7
Gilead Sciences
GILD
$165B
$3.41M 3.22%
29,100
-200
-0.7% -$21.9K
CMI icon
8
Cummins
CMI
$83.6B
$2.9M 2.75%
22,125
-100
-0.4% -$13.8K
NOC icon
9
Northrop Grumman
NOC
$76B
$2.9M 2.75%
18,300
-100
-0.5% -$16K
REGN icon
10
Regeneron Pharmaceuticals
REGN
$72.9B
$2.88M 2.72%
5,635
UNP icon
11
Union Pacific
UNP
$174B
$2.86M 2.7%
29,950
-9,600
-24% -$1M
HD icon
12
Home Depot
HD
$337B
$2.84M 2.69%
25,570
-200
-0.8% -$22.4K
LOW icon
13
Lowe's Companies
LOW
$121B
$2.81M 2.65%
41,880
-400
-0.9% -$28.5K
AAXJ icon
14
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.51B
$2.77M 2.62%
43,900
+17,400
+66% +$1.16M
APH icon
15
Amphenol
APH
$185B
$2.75M 2.6%
189,200
-1,200
-0.6% -$17.2K
LRCX icon
16
Lam Research
LRCX
$316B
$2.69M 2.54%
329,000
-3,000
-0.9% -$23.6K
EXPE icon
17
Expedia Group
EXPE
$36.5B
$2.61M 2.47%
+23,900
New +$2.47M
WFC icon
18
Wells Fargo
WFC
$254B
$2.59M 2.45%
46,100
-500
-1% -$27.9K
BIIB icon
19
Biogen
BIIB
$30.9B
$2.56M 2.43%
6,350
-50
-0.8% -$20.1K
ALXN
20
DELISTED
Alexion Pharmaceuticals
ALXN
$2.55M 2.41%
14,100
-100
-0.7% -$17.3K
VNM icon
21
VanEck Vietnam ETF
VNM
$478M
$2.37M 2.24%
+126,900
New +$2.25M
MDT icon
22
Medtronic
MDT
$112B
$2.31M 2.19%
31,050
+10,100
+48% +$772K
CTSH icon
23
Cognizant
CTSH
$25.2B
$2.21M 2.09%
36,200
-300
-0.8% -$18.8K
TXN icon
24
Texas Instruments
TXN
$248B
$2.14M 2.03%
41,600
+12,000
+41% +$662K
DIS icon
25
Walt Disney
DIS
$171B
$2.11M 2%
18,500
-200
-1% -$22K

Similar funds

Marvin & Palmer Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Marvin & Palmer Associates held 64 positions worth $106M, down 8.5% from $115M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Marvin & Palmer Associates withdrew a net $11.7M in Q2 2015, closing 14 positions and reducing 30 holdings. Its most notable exit was Vipshop, an estimated $2.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marvin & Palmer Associates opened a new position in Expedia Group worth $2.61M.

  • Marvin & Palmer Associates's largest Q2 2015 buy was Expedia Group: 23,900 shares worth $2.61M.
  • Marvin & Palmer Associates added most to JD.com in Q2 2015, an estimated $3.15M increase.
  • Marvin & Palmer Associates's biggest Q2 2015 reduction was Baidu, cutting an estimated $4.03M.
  • Marvin & Palmer Associates fully exited Vipshop in Q2 2015, selling an estimated $2.9M.
  • Marvin & Palmer Associates's ten largest holdings make up 42% of its $106M portfolio in Q2 2015.
  • Marvin & Palmer Associates opened 5 new positions and closed 14 in Q2 2015.
  • Marvin & Palmer Associates's portfolio value fell 8.5% quarter-over-quarter to $106M.

Based on Marvin & Palmer Associates's 13F filing for Q2 2015, filed 12 Aug 2015.